Výsledky vyhledávání - "Alex V Anstey"

Autor: Mahbub M U Chowdhury, Alex V Anstey

Publikováno v: Medicine. 28:12-16

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0842c3ca301ca56196a3dc81666b9ad7
https://doi.org/10.1383/medc.28.11.12.27500

Zobrazit plný text záznamu

Congenital and Acquired Photosensitivity

Autor: Alex V Anstey

Publikováno v: Medicine. 28:65-69

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79f0105a8609adf0f2f06eba8993f89f
https://doi.org/10.1383/medc.28.12.65.28035

Zobrazit plný text záznamu

Eye protection for ultraviolet B phototherapy and psoralen ultraviolet A patients

Autor: Suliman G H, Otman, Leila D, El-Dars, Chris, Edwards, Ejaz, Ansari, David, Taylor, Beverley, Gambles, Ian, Chalmers, Alex V, Anstey

Publikováno v: Photodermatology, photoimmunologyphotomedicine. 26(3)

We tested eye protection used for phototherapy patients. The study also established current practice concerning eye protection in a sample of UK phototherapy units.The ultraviolet (UV) transmission spectra of 30 'UV protective' contact lenses were me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1ed687c7b4f9da7a1bc37b33215cf068
https://pubmed.ncbi.nlm.nih.gov/20584253

Zobrazit plný text záznamu

Drug Reactions and the Skin

Autor: Alex V Anstey

Publikováno v: Medicine. 28:63-65

An adverse drug reaction is defined as an undesirable clinical effect arising from taking a particular drug. Drug rashes with commonly used drugs such as antibiotics are usually easy to recognize and manage. However, less commonly used drugs may prod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4b8ba310906e00afc56841a9e0caba4
https://doi.org/10.1383/medc.28.12.63.28036

Zobrazit plný text záznamu

Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment

Autor: Knud Kragballe, Alex V. Anstey

Publikováno v: International journal of dermatology. 45(8)

Background The US National Psoriasis Foundation recently recommended that PASI 50 and PASI 75 response rates be used in clinical trials to enable comparisons across studies of different psoriasis therapies. To date, these response rates have not been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e92fa8868d98def735e4fa0404162e
https://pubmed.ncbi.nlm.nih.gov/16911387

Zobrazit plný text záznamu